Tirzepatide Phase 3 study to evaluate real-world weight management and safety in obese adults
Efficacy and Safety of Tirzepatide for Weight Management
Abstract
A Phase 3 real-world study will evaluate tirzepatide 15 mg weekly for weight management and safety in 440 overweight or obese adults.